SCHEDULE: L1 Capital Discloses 11.64% Stake in Anteris Technologies
Ownership Filing Amendment
L1 Capital Pty Ltd has filed an amendment to its Schedule 13G, disclosing beneficial ownership of 11,496,345 shares, representing 11.64% of Anteris Technologies Global Corp.'s common stock.
Summary
- L1 Capital Pty Ltd has increased its beneficial ownership in Anteris Technologies Global Corp. to 11,496,345 shares.
- This holding represents 11.64% of the company's outstanding common stock.
- The filing is an amendment to a previous Schedule 13G filed on August 7, 2026.
- The reported shares include 4,803,541 shares of common stock, 5,359,470 CHESS Depository Instruments (CDIs), and 1,333,334 CDI warrants.
- The CDIs trade on the Australian Stock Exchange and each represent one underlying share of common stock.
- The CDI warrants are exercisable within 60 days at a price of AUD 11.50.
- The shares are held by L1 Long Short Fund Limited, L1 Capital Long Short Fund, and L1 Capital Long Short (Master) Fund, all managed by L1 Capital Pty Ltd.
- The percentage is based on 98,791,808 shares of common stock outstanding, including CDI warrants.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant ownership stake by an investment manager, which can signal confidence but doesn't inherently suggest immediate positive or negative performance changes.
Positives
- L1 Capital Pty Ltd, an Australian investment manager, has increased its stake, potentially signaling confidence in Anteris Technologies' future prospects.
- The disclosure includes a significant number of shares, CDIs, and exercisable warrants, indicating a substantial investment.
- The investment manager is regulated by ASIC, suggesting a professional and compliant approach to investment.
Negatives
- The filing does not provide specific details on the reasons for the increased stake or future investment plans.
- The CDI warrants are exercisable at AUD 11.50, which may represent a future dilution event if exercised.
Risks
- The exercisability of 1,333,334 CDI warrants at AUD 11.50 within 60 days could lead to increased share count and potential price pressure if not managed effectively.
- Changes in ownership by significant institutional investors can sometimes precede strategic shifts or market speculation.
Future Outlook
The filing does not contain explicit forward-looking statements or guidance from Anteris Technologies. However, the exercisability of CDI warrants within 60 days at AUD 11.50 suggests a potential near-term event related to capital or share structure.
Management Comments
- Joel Arber, Director at L1 Capital Pty Ltd, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Industry Context
StockSavvy.ai notes that significant stake disclosures by investment managers like L1 Capital are common in the biotechnology and medical device sectors, where Anteris Technologies operates. Such filings often precede or follow significant corporate developments or market movements.
Stakeholder Impact
- Shareholders may observe increased market activity or speculation due to the significant stake held by L1 Capital.
- Potential for increased liquidity or price volatility if the CDI warrants are exercised.
Next Steps
- The CDI warrants held by L1 Capital Pty Ltd are exercisable within 60 days at AUD 11.50, which may lead to a change in the number of outstanding shares or capital structure.
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Previous Schedule 13G/A filing date. |
| 2026-08-31 | Date of event requiring this filing amendment. |
| 2026-09-03 | Date of certification and signature for this filing. |
Recommendation
holdThe filing indicates a substantial ownership stake by a regulated investment manager, which is a positive signal of institutional interest. However, without further operational or financial updates from Anteris Technologies, the filing itself does not provide enough information to warrant a buy or sell recommendation. It suggests holding to monitor future developments.
Keywords
Anteris Technologies, L1 Capital, Schedule 13G, Beneficial Ownership, Common Stock, CDIs, Warrants, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.